Editorial
Who can benefit from postoperative radiotherapy following biochemical recurrence after radical prostatectomy?—looking for the “Rosetta Stone” of prostate cancer
Abstract
Over the last 10 years, there has been a growing interest to find a personalized and customized treatment approach for prostate cancer patients, aiming to optimize cancer control and improve functional outcomes.
